David Schaffer On Taking An Over $1.2 Billion Company Public And Now Building A Stem Cell Therapy Company

In the world of scientific innovation and entrepreneurship, few names shine as brightly as David Schaffer's. With a track record of launching and nurturing successful companies in the biomedical field, David's journey is not just a story of academic achievement.